Patents by Inventor Salvatore DIMAURO

Salvatore DIMAURO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of guaiacol for the prevention and treatment of glycogen storage disease
    Patent number: 10933031
    Abstract: The current invention is a method of preventing and treating certain diseases by preventing the synthesis and/or breakdown of glycogen by the administration of an agent, guaiacol. Diseases that can be prevented and treated by the administration of guaiacol include but are not limited to glycogen storage disease type IV (GSD-IV), adult polyglucosan body disease (APBD), and Lafora disease (LD). The invention also includes methods and tools for screening for agents that prevent and treat these diseases as well as basic research, specifically in the form of cells and cell lines that produce detectable polyglucosan.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: March 2, 2021
    Assignees: The Trustees of Columbia University in the City of New York, Hadasit Medical Research Services and Development Ltd., Ramot at Tel-Aviv University, Ltd.
    Inventors: Hasan Orhan Akman, Salvatore Dimauro, Or Kakhlon, Miguel Enrique Weil
  • USE OF GUAIACOL FOR THE PREVENTION AND TREATMENT OF GLYCOGEN STORAGE DISEASE
    Publication number: 20190015355
    Abstract: The current invention is a method of preventing and treating certain diseases by preventing the synthesis and/or breakdown of glycogen by the administration of an agent, guaiacol. Diseases that can be prevented and treated by the administration of guaiacol include but are not limited to glycogen storage disease type IV (GSD-IV), adult polyglucosan body disease (APBD), and Lafora disease (LD). The invention also includes methods and tools for screening for agents that prevent and treat these diseases as well as basic research, specifically in the form of cells and cell lines that produce detectable polyglucosan.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 17, 2019
    Applicants: The Trustees of Couumbia University in the City of New York, Hadasit Medical Research Services and Development Ltd.
    Inventors: Hasan Orhan AKMAN, Salvatore DIMAURO, Or KAKHLON